Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer

BACKGROUND: An association between CYP2D6 polymorphisms and tamoxifen (TAM) efficacy has not been confirmed, partly due to unreliable prediction of active metabolite exposure solely by CYP2D6 activity. The efficacy of TAM dose escalation appears limited in poor TAM metabolizers. Since the chlorine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Hiroshi, Ohno, Shinji, Yamamoto, Yutaka, Takao, Shintaro, Sato, Nobuaki, Fujisawa, Tomomi, Kadoya, Takayuki, Kuroi, Katsumasa, Bando, Hiroko, Teramura, Yasufumi, Iwata, Hiroji, Tanaka, Shiro, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694038/
https://www.ncbi.nlm.nih.gov/pubmed/30734152
http://dx.doi.org/10.1007/s12282-019-00952-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694038/
https://www.ncbi.nlm.nih.gov/pubmed/30734152
http://dx.doi.org/10.1007/s12282-019-00952-9

Ejemplares similares